Binding Free Energy Analysis of Programmed Cell Death Protein PD1 to its Ligand PD-L1

被引：0

作者：

Pan, Peter C. ^{[1
]}

Tafazzol, Alireza ^{[2
]}

Zhang, Xianwei ^{[3
]}

Duan, Yong ^{[2
]}

机构：

[1] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA

[2] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA

[3] Univ Calif Davis, Biophys Program, Davis, CA USA

来源：

BIOPHYSICAL JOURNAL | 2019年 / 116卷 / 03期

关键词：

D O I：

10.1016/j.bpj.2018.11.2576

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

2362-Pos

引用

页码：477A / 477A

页数：1

共 50 条

[41] Inhibition of programmed cell death protein ligand-1 (PD-L1) by benzyl ether derivatives: analyses of conformational change, molecular recognition and binding free energy
Sun, Xin
Liang, Li
Gu, Jinke
Zhuo, Wei
Yan, Xiao
Xie, Tao
Wu, Zhixiang
Liu, Xinyu
Gou, Xiaojun
Liu, Wei
He, Gang
Gan, Ya
Chang, Shan
Shi, Hubing
Hu, Jianping
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2019, 37 (18): : 4801 - 4812
[42] Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis
Matsuda, Kotaro
Miyoshi, Hiroaki
Hiraoka, Koji
Hamada, Tetsuya
Yoshida, Shiro
Ishibashi, Yukinao
Haraguchi, Toshiaki
Shiba, Naoto
Ohshima, Koichi
CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 18 (04) : 487 - 494
[43] Programmed Death Ligand 1 (PD-L1) Expression in Cervical Cancer
Aryakrishna S. Lathika
S. Lakshmi
Preethi T. Ramdas
Aswin Kumar
Susan Mathews
John Joseph
Aleyamma Mathew
Francis V. James
Indian Journal of Gynecologic Oncology, 2021, 19
[44] Programmed death ligand 1 (PD-L1) expression in parathyroid tumors
Pan, Boju
Wang, Anqi
Pang, Junyi
Zhang, Yuhan
Cui, Ming
Sun, Jian
Liang, Zhiyong
ENDOCRINE CONNECTIONS, 2019, 8 (07) : 887 - 897
[45] Clinicopathological value of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) expression in synovium of patients with rheumatoid arthritis
Kotaro Matsuda
Hiroaki Miyoshi
Koji Hiraoka
Tetsuya Hamada
Shiro Yoshida
Yukinao Ishibashi
Toshiaki Haraguchi
Naoto Shiba
Koichi Ohshima
Clinical and Experimental Medicine, 2018, 18 : 487 - 494
[46] Programmed Cell Death 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Expression Patterns in Ewing and Ewing-Like Sarcoma
Tamura, A.
Yoshida, M.
Yamamoto, N.
Nakamura, S.
Fujiwara, T.
Tahara, T.
Saito, A.
Kozaki, A.
Kishimoto, K.
Ishida, T.
Hasegawa, D.
Kosaka, Y.
PEDIATRIC BLOOD & CANCER, 2018, 65 : S336 - S336
[47] Expression of programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand (PD-L1) in adenocarcinomas of the gastroesophageal junction change significantly after neoadjuvant treatment
Jomrich, Gerd
Kollmann, Dagmar
Ramazanova, Dariga
Ristl, Robin
Grose, Richard P.
Ilhan-Mutlu, Ayseguel
Preusser, Matthias
Fassnacht, Christina
Tsai, Yi-Chien
Guenova, Emmanuella
Schoppmann, Sebastian F.
EJSO, 2022, 48 (02): : 383 - 390
[48] Analysis of Expression of Programmed Cell Death 1 Ligand 1 (PD-L1) in Malignant Pleural Mesothelioma (MPM)
Cedres, Susana
Ponce-Aix, Santiago
Zugazagoitia, Jon
Sansano, Irene
Enguita, Ana
Navarro-Mendivil, Alejandro
Martinez-Marti, Alex
Martinez, Pablo
Felip, Enriqueta
PLOS ONE, 2015, 10 (03):
[49] Programmed Death Ligand-1 (PD-L1) Expression in the Programmed Death Receptor-1 (PD-1)/PD-L1 Blockade A Key Player Against Various Cancers
Guan, Jian
Lim, Khin Sandar
Mekhail, Tarek
Chang, Chung-Che
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2017, 141 (06) : 851 - 861
[50] Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer type.
Gatalica, Zoran
Ghazalpour, Anatole
Holterman, Daniel
Xiao, Nianqing
Overberg, Peggy
Rose, Inge
Basu, Gargl Dan
Von Hoff, Daniel D.
Hamid, Omld
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

← 1 2 3 4 5 →